These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33787270)

  • 21. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: a focus on nano-albumin-bound drugs.
    Fanciullino R; Ciccolini J; Milano G
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):504-13. PubMed ID: 23871532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo.
    Gao Y; Nai J; Yang Z; Zhang J; Ma S; Zhao Y; Li H; Li J; Yang Y; Yang M; Wang Y; Gong W; Yu F; Gao C; Li Z; Mei X
    PLoS One; 2021; 16(4):e0250670. PubMed ID: 33909691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Albumin for Drug Delivery as a Diagnostic and Therapeutic Tool.
    Karami E; Mesbahi Moghaddam M; Kazemi-Lomedasht F
    Curr Pharm Biotechnol; 2024; 25(6):676-693. PubMed ID: 37550918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic sensitivity of paclitaxel to its delivery vehicles drives distinct clinical outcomes of paclitaxel formulations.
    Li Y; Chen N; Palmisano M; Zhou S
    Mol Pharm; 2015 Apr; 12(4):1308-17. PubMed ID: 25714793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumors.
    Lluch A; Alvarez I; Muñoz M; Seguí MÁ; Tusquets I; García-Estévez L
    Crit Rev Oncol Hematol; 2014 Jan; 89(1):62-72. PubMed ID: 24071503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Design Strategies for Controlling the Rate of Hydrophobic Drug Release from Nanoemulsions in Blood Circulation.
    Abbasi S; Sato Y; Kajimoto K; Harashima H
    Mol Pharm; 2020 Oct; 17(10):3773-3782. PubMed ID: 32881529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?
    Li C; Li Y; Gao Y; Wei N; Zhao X; Wang C; Li Y; Xiu X; Cui J
    Int J Pharm; 2014 Jul; 468(1-2):15-25. PubMed ID: 24709221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albumin as a drug delivery and diagnostic tool and its market approved products.
    Sethi A; Sher M; Akram MR; Karim S; Khiljee S; Sajjad A; Shah SN; Murtaza G
    Acta Pol Pharm; 2013; 70(4):597-600. PubMed ID: 23923383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy.
    Lamichhane S; Lee S
    Arch Pharm Res; 2020 Jan; 43(1):118-133. PubMed ID: 31916145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albumin-coated nanocrystals for carrier-free delivery of paclitaxel.
    Park J; Sun B; Yeo Y
    J Control Release; 2017 Oct; 263():90-101. PubMed ID: 28049022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity.
    Ma X; Wang H; Jin S; Wu Y; Liang XJ
    Int J Nanomedicine; 2012; 7():1313-28. PubMed ID: 22419875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microemulsion and bovine serum albumin nanoparticles as a novel hybrid nanocarrier system for efficient multifunctional drug delivery.
    Gharbavi M; Danafar H; Sharafi A
    J Biomed Mater Res A; 2020 Aug; 108(8):1688-1702. PubMed ID: 32196926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Learning from nature: the role of albumin in drug delivery.
    Matos MJ
    Future Med Chem; 2018 May; 10(9):983-985. PubMed ID: 29629571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.
    Mattu C; Pabari RM; Boffito M; Sartori S; Ciardelli G; Ramtoola Z
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):463-72. PubMed ID: 23916461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of serum proteins on drug delivery.
    Kratz F; Elsadek B
    J Control Release; 2012 Jul; 161(2):429-45. PubMed ID: 22155554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and physicochemical characterization of a novel paclitaxel-loaded amphiphilic aminocalixarene nanoparticle platform for anticancer chemotherapy.
    Weeden C; Hartlieb KJ; Lim LY
    J Pharm Pharmacol; 2012 Oct; 64(10):1403-11. PubMed ID: 22943171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
    Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
    Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases.
    Ernsting MJ; Murakami M; Undzys E; Aman A; Press B; Li SD
    J Control Release; 2012 Sep; 162(3):575-81. PubMed ID: 22967490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.